← Back to Analyst Consensus 
VVOS Buy
Vivos Therapeutics, Inc.
Current Price —
Implied Upside —
Analysts 9
30-Day Momentum
▲ 0 upgrades / ▼ 0 downgrades / 0 reiterations from 0 firms
Next Earnings
Nov 17, 2026 (22 days)
Rating Timeline
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Jun 4, 2026 | Ascendiant Capital | maintain | Buy → Buy | — | 38% |
| Apr 22, 2026 | Ascendiant Capital | maintain | Buy → Buy | — | 38% |
| Apr 17, 2026 | HC Wainwright& Co. | maintain | Buy → Buy | — | — |
| Apr 17, 2026 | HC Wainwright & Co. | maintain | Buy → Buy | — | 44% |
| Dec 3, 2025 | Ascendiant Capital | maintain | Buy → Buy | $5.5 | 38% |
| Nov 17, 2025 | HC Wainwright & Co. | initiate | — → Buy | $7 | 44% |
| Sep 9, 2025 | Ascendiant Capital | maintain | Buy → Buy | $6.5 | 38% |
| Apr 15, 2025 | Ascendiant Capital | maintain | Buy → Buy | $6.2 | 38% |
| Nov 20, 2024 | Ascendiant Capital | reiterate | Buy → Buy | $6.6 | 38% |
| Nov 19, 2024 | Alliance Global Partners | maintain | Buy → Buy | $6 | 41% |
| Aug 20, 2024 | Ascendiant Capital | maintain | Buy → Buy | $6.6 | 38% |
Price Target Trend
Apr 2, 2026 Latest: $2.12 Oct 25, 2026
EPS Estimates
0q $-0.30
Lo: $-0.54 Hi: $-0.12
4 analysts +1y $-0.82
Lo: $-2.17 Hi: $-0.10
3 analysts 0y $-1.34
Lo: $-2.14 Hi: $-0.75
4 analysts ▲1
+1q $-0.25
Lo: $-0.52 Hi: $-0.07
4 analysts Cross-Platform Signals
No cross-platform signals in the last 90 days